Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Lantern Pharma
LTRN
$33.8M
| $253K | ﹤0.01% |
44,900
+20,300
| +83% | +$105K |
|
3202
Village Farms International
VFF
$311M
| $253K | ﹤0.01% |
421,966
+84,198
| +25% | +$59.9K |
|
|
DMTK
3203
DELISTED
DermTech, Inc. Common Stock
DMTK
| $253K | ﹤0.01% |
97,269
+50,269
| +107% | +$150K |
|
3204
Creative Realities
CREX
$41.9M
| $251K | ﹤0.01% |
82,203
+23,600
| +40% | +$61.5K |
|
|
3205
Amazon
AMZN
$2.87T
| $250K | ﹤0.01% |
1,925
-8,999,016
| -100% | -$1.03B |
|
3206
ProShares UltraShort Dow 30
DXD
$42.6M
| $250K | ﹤0.01% |
+6,200
| New | +$261K |
|
3207
Axogen
AXGN
$2.58B
| $249K | ﹤0.01% |
+27,300
| New | +$254K |
|
3208
Fathom Holdings
FTHM
$24.9M
| $249K | ﹤0.01% |
34,900
-500
| -1% | -$2.8K |
|
3209
iShares Dow Jones US ETF
IYY
$3.09B
| $249K | ﹤0.01% |
+2,300
| New | +$235K |
|
3210
iShares North American Natural Resources ETF
IGE
$780M
| $248K | ﹤0.01% |
+6,400
| New | +$247K |
|
3211
Astec Industries
ASTE
$989M
| $247K | ﹤0.01% |
5,445
-4,900
| -47% | -$202K |
|
|
SSY
3212
DELISTED
SunLink Health Systems
SSY
| $246K | ﹤0.01% |
270,878
-1,700
| -0.6% | -$1.68K |
|
3213
GigaCloud Technology
GCT
$1.89B
| $245K | ﹤0.01% |
36,300
+22,100
| +156% | +$137K |
|
3214
Forestar Group
FOR
$1.49B
| $244K | ﹤0.01% |
+10,800
| New | +$208K |
|
|
EXAI
3215
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $244K | ﹤0.01% |
41,200
-43,400
| -51% | -$266K |
|
3216
CuriosityStream
CURI
$230M
| $243K | ﹤0.01% |
260,800
+26,500
| +11% | +$26.5K |
|
3217
Harley-Davidson
HOG
$2.87B
| $243K | ﹤0.01% |
6,900
-10,300
| -60% | -$360K |
|
3218
Hawthorn Bancshares
HWBK
$277M
| $243K | ﹤0.01% |
+13,543
| New | +$261K |
|
3219
Momentus
MNTS
$93.2M
| $243K | ﹤0.01% |
62
+57
| +1,140% | +$269K |
|
|
TIGR
3220
UP Fintech Holding
TIGR
$827M
| $243K | ﹤0.01% |
85,400
+27,100
| +46% | +$80.2K |
|
3221
Broadway Financial
BYFC
$105M
| $242K | ﹤0.01% |
31,139
-7,313
| -19% | -$57.3K |
|
|
STBX
3222
DELISTED
Starbox Group Holdings Ltd. Class A Ordinary Shares
STBX
| $242K | ﹤0.01% |
+32
| New | +$227K |
|
3223
Aura Biosciences
AURA
$792M
| $241K | ﹤0.01% |
19,500
+9,400
| +93% | +$100K |
|
3224
Red River Bancshares
RRBI
$681M
| $241K | ﹤0.01% |
4,900
-2,600
| -35% | -$127K |
|
3225
Schwab U.S Small- Cap ETF
SCHA
$23.5B
| $241K | ﹤0.01% |
+11,000
| New | +$229K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.